ACE-031
Soluble activin receptor type IIB · ActRIIB-Fc
Think of it as a muscle-building bouncer.
ACE-031 acts like a bouncer at a club, keeping certain proteins from getting in and messing with your muscle growth. Normally, proteins like myostatin put the brakes on muscle building, but ACE-031 blocks these proteins, potentially allowing for more muscle mass.
Early studies showed promising results for increasing lean body mass, especially in contexts where muscle growth is beneficial, like in postmenopausal women. However, despite these initial gains, research hit a pause due to some non-muscle-related safety concerns.
Who it's for
- Fitness enthusiasts looking for cutting-edge muscle-building insights
- Bodybuilders curious about future muscle growth technologies
- Athletes interested in muscle mass research
Probably not for you if…
- Anyone seeking FDA-approved muscle growth solutions
- Individuals uncomfortable with experimental therapies
- Those prioritizing safety-confirmed products
Editorial summary for research context · Not medical advice
Mechanism of Action
ACE-031 is a recombinant fusion protein combining the extracellular domain of the activin receptor type IIB with an Fc region. Acting as a decoy receptor, it binds myostatin, activin, and related TGF-β family ligands in circulation, preventing them from activating muscle-cell ActRIIB and downstream Smad signaling. Early-phase human trials (Acceleron Pharma) in Duchenne muscular dystrophy showed lean-mass gains but were discontinued in 2013 due to non-muscle safety signals (epistaxis, telangiectasias). ACE-031 is not FDA-approved.
Researched Benefits
Myostatin and activin pathway blockade
Preclinical and Phase 1 data demonstrate ActRIIB-Fc inhibits multiple negative regulators of muscle mass.
- [Attie et al. 2013]
Lean mass increase in early human trials
A Phase 1 study in healthy postmenopausal women showed increases in lean body mass and bone formation markers.
- [Attie et al. 2013]
Explored in Duchenne muscular dystrophy
Phase 2 trials in DMD showed initial functional signals before discontinuation due to safety concerns.
- [Campbell et al. 2017]
Research Protocols
The following dosing ranges have appeared in published research protocols. Presented for informational purposes only — not a recommendation for human use.
Historical Phase 1 research dose
- Dosage
- 1 mg
- Frequency
- every 4 weeks
- Timing
- any time
- Cycle
- 12 weeks
Research protocols in the discontinued clinical program used mg/kg IV/SC dosing every 3-4 weeks; ACE-031 is no longer in active human development.
Reported Side Effects
- Epistaxis (nosebleeds) — cited reason for clinical program discontinuation
- Telangiectasias (small dilated blood vessels)
- Injection-site reactions
- Gum/mucosal bleeding reports
- Theoretical off-target effects on other TGF-β pathway tissues
- Long-term human safety data is absent
Contraindications
- Active or suspected malignancy
- Bleeding disorders or anticoagulant therapy
- Pregnancy and lactation
- Vascular disease
Stacking Partners
Peptides commonly paired with ACE-031 in published research and protocol write-ups.
Vendor Pricing
Stacked earns a commission on purchases via these links. It does not influence our Trust Scores.
Gear + Companions
Reconstitution supplies and research-backed supplement companions for ACE-031. Editorial picks only — we earn a commission through Amazon on the click, no sponsorship.
Gear you'll need
· Reconstitution + storage essentialsBacteriostatic Water 30mL (0.9% Benzyl Alcohol)
Empower Pharmacy / generic medical supply
Reconstitutes every lyophilized peptide. 28-day viability refrigerated.
Insulin Syringes 31G × 5/16" × 0.5mL (100 count)
EasyTouch
31G × 0.5mL insulin syringes — the default size for sub-0.25mL peptide doses.
Alcohol Prep Pads (Sterile, 200 count)
Dynarex
Sterile 70% IPA prep pads — one per vial stopper + one per injection site.
1-Quart Sharps Disposal Container
BD / Becton Dickinson
FDA-cleared sharps container — pharmacies won't accept improvised disposal.
As an Amazon Associate we earn from qualifying purchases · Disclosed per FTC guidelines
Top Videos
Curated from YouTube — refreshed weekly. Stacked doesn't host or endorse external content.
12:37Dr. Explains Peptide Stacks Used for Muscle Growth
This Is Not Covered - Dr. Ashley Froese
1.1M views · 12:37 · 4 months ago
6:04Doctor Explains 20 Most Powerful Peptides
This Is Not Covered - Dr. Ashley Froese
472.6K views · 6:04 · 7 months ago
7:43Why I Stopped BPC-157 and TB-500 Peptides - April 26, 2024
Bill Maeda
366.9K views · 7:43 · 2 years ago
5:59TIER LIST PEPTIDE EDITION
Greg Doucette
351.9K views · 5:59 · 1 year ago
12:39Tired of Zero Progress? Try This Instead
Joey Thurman
253.9K views · 12:39 · 4 years ago
Research Papers
A single ascending-dose study of muscle regulator ACE-031 in healthy volunteers
Attie KM, et al. · Muscle & Nerve · 2013
PubMed 23169607 →



